Lv6
1820 积分 2023-07-05 加入
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
2天前
已完结
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
7天前
已完结
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
9天前
已完结
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
15天前
已完结
Impact of TP53 Co-Mutation on Clinicopathological Features, Prognosis, Recurrence Patterns, and the Efficacy of EGFR-TKI Treatment After Recurrence in Resected Early-Stage EGFR-Mutated Lung Adenocarcinoma
20天前
已完结
The Pharmacogenomics "Side-effect" of TP53/EGFR in Non-small Cell Lung Cancer Accompanied with Atorvastatin Therapy: A Functional Network Analysis
29天前
已完结
Proteomic insights into the molecular mechanism of anlotinib inhibition in TP53-mutated non-small cell lung cancer
29天前
已关闭
The clinical features and prognostic implications of the co-mutated TP53 gene in advanced non-small cell lung cancer
29天前
已完结
First-line lorlatinib treatment in a 19-year-old patient with ALK-rearranged pulmonary large-cell neuroendocrine carcinoma: a case report and literature review
1个月前
已完结
Advances in Systemic Therapy for Lung Cancer
1个月前
已关闭
皖公网安备34019202002308
